Mackenzie Financial’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-97,443
| Closed | -$9.68M | – | 1193 |
|
|
2019
Q3 | $9.68M | Buy |
97,443
+7,997
| +9% | +$760K | 0.03% | 335 |
|
|
2019
Q2 | $8.27M | Sell |
89,446
-11,023
| -11% | -$1.05M | 0.02% | 345 |
|
|
2019
Q1 | $9.48M | Sell |
100,469
-741,767
| -88% | -$64.9M | 0.02% | 380 |
|
|
2018
Q4 | $54M | Sell |
842,236
-253,732
| -23% | -$18.7M | 0.14% | 148 |
|
|
2018
Q3 | $98.1M | Buy |
1,095,968
+9,113
| +0.8% | +$805K | 0.24% | 113 |
|
|
2018
Q2 | $86.3M | Buy |
1,086,855
+464,276
| +75% | +$38.5M | 0.22% | 118 |
|
|
2018
Q1 | $55.5M | Buy |
622,579
+497,937
| +399% | +$47.8M | 0.14% | 154 |
|
|
2017
Q4 | $13M | Buy |
+124,642
| New | +$14.1M | 0.03% | 313 |
|
|
2016
Q4 | – | Sell |
-19,556
| Closed | -$2.04M | – | 783 |
|
|
2016
Q3 | $2.04M | Sell |
19,556
-285,330
| -94% | -$30.9M | 0.01% | 328 |
|
|
2016
Q2 | $30.1M | Sell |
304,886
-41,679
| -12% | -$4.31M | 0.17% | 146 |
|
|
2016
Q1 | $34.7M | Sell |
346,565
-2,165
| -0.6% | -$223K | 0.31% | 79 |
|
|
2015
Q4 | $41.8M | Buy |
348,730
+8,785
| +3% | +$1.02M | 0.26% | 100 |
|
|
2015
Q3 | $36.8M | Sell |
339,945
-28,256
| -8% | -$3.51M | 0.22% | 100 |
|
|
2015
Q2 | $42.6M | Buy |
368,201
+74,730
| +25% | +$8.54M | 0.23% | 102 |
|
|
2015
Q1 | $33.8M | Buy |
293,471
+145,770
| +99% | +$17.4M | 0.18% | 134 |
|
|
2014
Q4 | $16.5M | Buy |
147,701
+80,410
| +119% | +$8.48M | 0.08% | 194 |
|
|
2014
Q3 | $6.38M | Sell |
67,291
-40,589
| -38% | -$3.66M | 0.03% | 296 |
|
|
2014
Q2 | $9.27M | Sell |
107,880
-20,228
| -16% | -$1.54M | 0.04% | 266 |
|
|
2014
Q1 | $8.94M | Buy |
128,108
+16,500
| +15% | +$1.31M | 0.04% | 264 |
|
|
2013
Q4 | $9.43M | Buy |
111,608
+46,100
| +70% | +$3.65M | 0.05% | 244 |
|
|
2013
Q3 | $5.05M | Buy |
65,508
+47,168
| +257% | +$3.31M | 0.03% | 301 |
|
|
2013
Q2 | $1.07M | Buy |
+18,340
| New | +$1.1M | 0.01% | 480 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Mackenzie Financial's CELG Position: Q4 2019 in Review
Mackenzie Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 97,443 shares — an estimated $9.68M sold.
Mackenzie Financial first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $98.1M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Mackenzie Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Mackenzie Financial sold 97,443 Celgene Corp shares in Q4 2019, an estimated $9.68M.
- Mackenzie Financial first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
- Mackenzie Financial's Celgene Corp position peaked at $98.1M in Q3 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Mackenzie Financial's 13F filing for Q4 2019, filed 13 Feb 2020.